TXNDC12 and hepatocellular carcinoma: To further investigate the clinical significance of TXNDC12 expression in HCC, all 106 HCC patients were divided into two groups based on the overall expression level of TXNDC12: the high TXNDC12 expression group (n = 60) and the low TXNDC12 expression group (n = 46).